MAP3K13 Antikörper (AA 52-305)
Kurzübersicht für MAP3K13 Antikörper (AA 52-305) (ABIN7875559)
Target
Alle MAP3K13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 52-305
-
Verwendungszweck
- MAP3K13 Antibody
-
Aufreinigung
- Purified
-
Immunogen
- A portion of amino acids 52-305 from the human protein was used as the immunogen for the MAP3K13 antibody.
-
Isotyp
- IgM
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the MAP3K13 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the MAP3K13 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
-
Andere Bezeichnung
- MAP3K13
-
Hintergrund
- Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
-
UniProt
- O43283
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2
Target
-